Outcomes of lung cancer diagnosis and treatment

December 2005
Thorax;Dec2005 Supplement 2, Vol. 60, pii29
Academic Journal
The article presents abstracts on research related to lung cancer's diagnosis and treatment. They include "Change in Practice in the Diagnosis of Lung Cancer in Greenwich 1998-2004," by E.E. Strawson, A. Patterson, T.C. Stokes and J.R. Webb, "Lung Cancer Care in Liverpool: Reaudit Eight Years On," by S. Bari, J. Hughes, D.A. Stock, C.M. Smyth, M.J. Walshaw and M.J. Ledson, "Lung Cancer Outcomes in a UK Cancer Centre: Can We Do Better?," by C.M. Free, M. Ellis and D.R. Baldwin, and "Cancer Waiting Time Targets and Tumor Stage at Surgery for Lung Cancer," by V. Kelly, J. Maguire, M. Ledson, C. Smyth, M. Jackson, and M. Walshaw.


Related Articles

  • Karmanos Institute part of lung-cancer breath-test study. Merx, Katie // Crain's Detroit Business;3/22/2004, Vol. 20 Issue 12, p16 

    The Barbara Ann Karmanos Cancer Institute is participating in tests to determine whether lung cancer can be detected through the analysis of a patient's breath. So far, the breath test has detected lung cancer with some accuracy. The success rates for curing lung cancer are good when it is...

  • 3rd European Lung Cancer Conference: Journal of Thoracic Oncology: Promising developments in early diagnosis and treatment of mesothelioma.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article focuses on a research presented at the at third European Lung Cancer Conference being held in Geneva, Switzerland which revealed important steps being made to improve the diagnosis and treatment of malignant pleural mesothelioma, an aggressive cancer of lungs caused by asbestos exposure.

  • JAMA: Low-dose CT screening may benefit individuals at increased risk for lung cancer.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article offers information on the benefits and harms of low dose computerized tomography (LDCT) related with lung cancer screening.

  • Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung Cancer. Picard, Evelyne; Seguin, Carole // JNCI: Journal of the National Cancer Institute;06/16/99, Vol. 91 Issue 12, p1059 

    Presents information on a study which investigated whether abnormalities in the in vivo expression of retinoid receptors are observed in the non-small-cell lung cancer (NSCLC). Methodology; Results; Discussion.

  • DEEP BREATH. TALKS, ALEX // Cincinnati Magazine;Jan2013, Vol. 47 Issue 4, p88 

    A personal narrative is presented which explores the author's experience working with radiology diagnosis for lung cancer and doing surgery for lung cancer patients at the University of Cincinnati Health Cancer Institute.

  • Low-dose CT screening reduced lung cancer mortality 20%.  // Hem/Onc Today;7/25/2011, Vol. 12 Issue 14, p14 

    The article focuses on the findings of the National Lung Screening Trial (NLST) on low-dose lung cancer screening for people at high risk for lung cancer.

  • Physical activity preferences of early-stage lung cancer survivors. Philip, Errol; Coups, Elliot; Feinstein, Marc; Park, Bernard; Wilson, Donna; Ostroff, Jamie // Supportive Care in Cancer;Feb2014, Vol. 22 Issue 2, p495 

    Purpose: Engagement in physical activity can provide important benefits for cancer patients and survivors, including those diagnosed with lung cancer. Despite this, many survivors do not engage in recommended levels of physical activity and little is known about the obstacles encountered by lung...

  • Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Borner, M.M.; Brousset, P.; Pfanner-Meyer, B.; Bacchi, M.; Vonlanthen, S.; Hotz, M.A.; Altermatt, H.J.; Schlaifer, D.; Reed, J.C.; Betticher, D.C. // British Journal of Cancer;2/15/99, Vol. 79 Issue 5/6, p952 

    Proteins of the Bcl-2 family as well as p53 are important regulators of apoptosis. Alterations in the expression of these proteins can contribute to the formation of cancer, as well as influence tumour response to chemo- and radiotherapy. We used antibodies specific for the human Bcl-2, Mcl-1,...

  • Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.  // Thorax;Jun2013, Vol. 68 Issue 6, p551 

    Background The authors consider whether differences in stage at diagnosis could explain the variation in lung cancer survival between six developed countries in 2004-2007. Methods Routinely collected population-based data were obtained on all adults (15-99 years) diagnosed with lung cancer in...


Read the Article


Sign out of this library

Other Topics